Treatment of early relapse of FLTIII-ITD plus AML after alloSCT with DLI and midostaurin

Weigel, M; Vaizian, R; Busemann, C; Hirt, C; Grunwald, U; Neumann, T; Schneidewind, L; Schmidt, CA; Kruger, WH

ONCOLOGY RESEARCH AND TREATMENT, 2018; 41 (): 71